Optical imaging device serves as a standard tool in preclinical drug discovery and development. This modality offers a virtual window inside the animals, thus facilitating the tracking of biological activities at the molecular level. This method is simple to use, offers fast throughput, is reasonably priced with outstanding sensitivity, and does not emit radiations.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- Berthold Technologies GmbH & Co.KG
- Endress+Hauser (Analytik Jena US LLC)
- Fujifilm Corporation (Fujifilm VisualSonics Inc.)
- LI-COR Biosciences, Inc.
- Miltenyi Biotec
- PerkinElmer, Inc.
- Rigaku Corporation (MILabs B.V.)
- TriFoil Imaging
- Vieworks Co., Ltd.
- Vilber Smart Imaging Ltd.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/10711
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By modality, bioluminescence & fluorescence imaging systems was the highest contributor to the market in 2020.
- By end user, contract research organizations segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
- By region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
The growth of the optical preclinical imaging market is majorly driven by technological developments in molecular imaging, surge in demand for noninvasive small animal imaging techniques, and increase in publicโprivate efforts, and financing for advanced research. In addition, emergence of new diseases, discovery of new molecules and their clinical trials further boost the growth of the market.
For instance, according to the USFDAโs Center for Drug Evaluation and Research (CDER) in 2020 about 53 new molecular entities (NMEs) were approved. Thus, rise in such drug approvals and innovations further drives the market. However, high cost of installation, other related expenditures related to optical preclinical imaging, and stringent government regulations are expected to impede the market growth.
According to the USFDA, more than 100,000 human deaths are caused annually due to adverse drug reactions. Adverse drug reactions are the fourth major cause of death in the U.S. Therefore, ensuring an effective approach in drug development studies to facilitate the development of novel drug candidates and limit the occurrence of drug failure in clinical trials compels the biotechnological and pharmaceutical companies to adopt modern optical preclinical imaging technologies, which is anticipated to offer remunerative opportunities for the expansion of the market. Moreover, establishment of reference laboratories across the global for preclinical studies is further anticipated to drive the growth of the market.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/10711
North America accounted for a majority of the global optical preclinical imaging market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of advanced technologies, presence of key players, and rise healthcare expenditure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in R&D activities in preclinical studies, and increase in investments in the healthcare sector in the region.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com